Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanMyeloablative AgonistsMultiple MyelomaTreatment OutcomeStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraLymphocytesRecurrenceTissue DonorsRemission InductionLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionImmunosuppressive AgentsTransplantation, IsogeneicVidarabineRetrospective StudiesHematopoiesisAmyloidosisLeukemiaSalvage TherapyIfosfamideSurvival RateBlood CellsVincristineSurvival AnalysisCarmustineGraft vs Leukemia EffectHodgkin DiseaseCytarabineTime FactorsLeukemia, Myeloid, AcutePlatelet CountCytomegalovirus InfectionsMyelodysplastic SyndromesLymphocyte DepletionAnemia, AplasticBlood Cell CountLymphomaCytophagocytosisLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasmsFatal OutcomeLymphocyte SubsetsT-LymphocytesHistiocytosis, Non-Langerhans-CellLivedo ReticularisFeasibility StudiesFollow-Up StudiesImmunophenotypingOpportunistic InfectionsHematologic DiseasesHLA AntigensCyclosporineBone MarrowDoxorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaBlood DonorsImmunosuppressionLymphocyte ActivationRecombinant ProteinsProspective StudiesLymphoma, T-CellMesenchymal Stem Cell TransplantationLeukocyte CountAntigens, CDPrednisoneBone Marrow PurgingPilot ProjectsCarboplatinFlow Cytometry